INTRODUCTION
============

The detection of respiratory syncytial virus (RSV) decreases the probability of a concurrent bacterial illness in infants with fever without source.[@b1-wjem-11-60]--[@b3-wjem-11-60] The clinical presentation of RSV is highly variable. It causes more than half of all cases of bronchiolitis.[@b4-wjem-11-60],[@b5-wjem-11-60] Other viruses are responsible for almost all of the remainder.[@b4-wjem-11-60],[@b6-wjem-11-60]--[@b9-wjem-11-60]

Bronchiolitis itself is a clinically recognizable viral illness; consequently, a low prevalence of culture-proven serious bacterial illness (SBI) would be anticipated.[@b10-wjem-11-60]--[@b12-wjem-11-60] This raises the question whether bronchiolitis caused by RSV as distinct from bronchiolitis caused by other viruses has a different prevalence of bacterial co-infection and therefore warrants a different emergency department (ED) evaluation.

The primary purpose of this study was to identify those clinical factors most likely associated with SBI and positive ED screening tests in children with bronchiolitis. The secondary purpose was to identify factors associated with obtaining these screening tests and cultures.

METHODS
=======

Underlying assumptions
----------------------

We made the following assumptions about emergency physicians' (EP) risk tolerance: (1) a positive screening test for SBI would prompt a change in management regardless of subsequent outcomes (since these cannot be known ahead of time); (2) EPs would not want to miss an infant who had a positive culture despite a (false) negative screening test.

We made the following assailable but unavoidable assumptions about bacterial illness in these patients. Firstly, we assumed that if both screening tests and cultures were negative that SBI was absent. Secondly, we assumed if no screening was performed without any adverse clinical outcomes three days post-ED visit, then SBI was absent. We anticipated that the outcomes we were seeking would be sufficiently rare that our primary analysis would require a combined endpoint rather than separate analyses of several single endpoints.

Study Design
------------

Our Institutional Review Board approved this study. We conducted a retrospective review using existing patient records and an existing database of ED patients prospectively enrolled into an RCT over three bronchiolitis seasons.[@b5-wjem-11-60]

Setting and Population
----------------------

The parent study was conducted at two centers; this study used data only from the primary study site. The primary study site was a county teaching hospital ED with an annual census of 53,000 (23% children less than 14 years) serving a mixed urban, suburban, and rural population.

Bronchiolitis was defined as clinical evidence of lower airway obstruction (physical findings of wheezing and chest wall retractions) following an upper respiratory tract infection. The eighteenth month of life was chosen as the upper age limit. This represents a compromise between competing views as to an appropriate definition of the diagnosis.[@b5-wjem-11-60],[@b10-wjem-11-60]

Neonate was defined as age up to 28 days. Dehydration and retraction severity were each described using scales from a validated bronchiolitis severity assessment tool.[@b13-wjem-11-60] The inter rater reliability of these individual variables and that of the severity of illness tool been described elsewhere.[@b14-wjem-11-60] Fever was defined as rectal temperature ≥38.0°C.

Patients were enrolled consecutively. Those with bronchiolitis so mild as to not require bronchodilator treatment and those with illness so severe as to require immediate intubation were excluded. These criteria reflect the design of the parent study, a randomized controlled trial of bronchodilators in bronchiolitis. We restricted this study to patients from that study to ensure the quality of data collected. Patients who received bronchodilators in the ED prior to screening for the parent study were excluded from that study and also from this. Although the patients included in this study reflect the parent study design, it is difficult to imagine an EP prescribing antibiotics in infants with bronchiolitis so mild as to not be eligible for the original trial, or withholding them in patients intubated for bronchiolitis.

Patients were recruited between November 1, 2003 and May 1, 2006. Potentially eligible children were identified by trained research assistants, residents and faculty. Diagnosis was made by an attending physician or midlevel provider. Clinical findings, including prior antibiotic and steroid use, were recorded on a specifically designed data collection. Laboratory testing was ordered at the physician's discretion.

Laboratory tests
----------------

We performed RSV antigen detection on nasal aspirates samples using the BD Directigen™ RSV Test Kit (Becton, Dickinson and Company, Franklin Lakes, NJ).

We performed urinalysis and cultures on catheterized specimens. Urinalysis was performed with an Iris iQ200 Automated Urine Microscopy Analyzer (Iris Diagnostics, Chatsworth, CA). Urine culture was performed using the calibrated-loop method on well-mixed, uncentrifuged specimens on blood agar and MacConkey agar plates. Low colony count plates (recommended if the child has received antibiotics prior to the sample being obtained) were used if specified by the physician. Results were reported after 48 hours of incubation. Cerebrospinal fluid (CSF) specimens were processed for protein, glucose, red and white blood cell counts (RBC, WBC), gram stain (GS) and cultures. Blood cultures were processed using the BacT/ALERT system (bioMérieux, Marcy l'Etoile, France), and their results were generally available after 48 hours.

Study Protocol
--------------

We obtained clinical data from the study database. Testing results were obtained from the hospital laboratory database. The clinical record was reviewed by first and second authors to determine whether positive cultures were treated by the physician.

Outcome measures:
-----------------

An ED septic screen (EDSS) was considered positive if urine or CSF analysis showed ≥10 WBC per high power field (\>25 WBC in neonates) or organisms were identified on gram stain regardless of subsequent culture being positive or negative. CSF WBC counts were corrected assuming one additional WBC to be normal for every 500 RBCs present.

We defined culture-proven SBI as a significant growth of a known bacterial pathogen in urine (10,000 or more colony-forming units per milliliter of a single pathogenic organism on a catheterized specimen), CSF or blood regardless of initial urine or CSF WBC results. When more than one organism was detected in a urine culture the specimen was considered contaminated. We considered blood cultures contaminated if they grew organisms commonly not accepted as pathogens (such as coagulase-negative *staphylococcus*, diphtheroids, and alpha- or gamma-hemolytic *streptococcus*).

We created a composite endpoint comprised of either a positive EDSS or a culture-proven SBI, or both. Patients who did not have laboratory tests and were alive 72 hours post-ED discharge (as assessed by telephone follow-up) were assumed not to have had either an SBI or the composite endpoint. In cases where both telephone and written follow-up failed, and a review of hospital medical records showed no further contact with the patient, the county coroner's records were used to determine vital status.

We did not address the possibility of pneumonia as an SBI because of the inability to differentiate a viral from a bacterial cause on chest x-ray.

Data analysis
-------------

We compared the prevalence of outcomes between RSV-positive and RSV-negative groups using Fisher's exact test for categorical data. We analyzed the importance of age, gender, presence of fever, clinical exam findings, and prior community antibiotic use on outcomes using logistic regression multivariate analysis. A modified multivariate Poisson analysis[@b15-wjem-11-60] was performed to determine factors associated with having an EDSS performed or not performed. We used logistic regression modified for rare events to account for biased standard logistic regression estimates in the case of a rare outcome.[@b16-wjem-11-60],[@b17-wjem-11-60] We performed model diagnostics on the standard logistic regression model as described in other medical literature using this technique.[@b18-wjem-11-60] Tests reached statistical significance at *p* ≤ .05. We used Stata 9.2 statistical software, (Statacorp LP, College Station TX), for all analyses.

RESULTS
=======

Data were available for 640 patients. RSV antigen testing was performed in 608 (95%) of these 640. The ED ordered RSV testing in 553 cases, the admitting pediatric service ordered it in 55. Three hundred thirty-four patients (54.9%) tested positive for RSV antigen, 271 (44.6%) tested negative and in 3 (0.5%) results were equivocal.

The median age of patients was 4.8 months. Patients' clinical and demographic characteristics are grouped by RSV status in [Table 1](#t1-wjem-11-60){ref-type="table"}.

ED testing to rule out bacterial illness was performed in 199/640 (31.1%) of patients. There were differences between children in whom physicians did and did not perform testing for bacterial illness. Those investigated were more likely to be younger than two months RR 2.69 (95% CI 2.11, 3.44), be febrile RR 2.01 (95% CI 1.58, 2.55), be more dehydrated RR 1.50 (95% CI 1.28, 1.75), and have more severe chest wall retractions RR 1.54 (95% CI 1.22, 1.94). RSV antigen results did not dissuade physicians from testing, RR 0.82 (95%CI 0.65, 1.04).

Although 14 patients were treated as having a positive EDSS or SBI by their treating physicians, our study definitions led us to discount three cases. These are shown in [Table 2](#t2-wjem-11-60){ref-type="table"}. Using study definitions, the combined endpoint of a positive septic screen, culture-proven SBI, or both occurred in 2/334 (0.6%, 95% CI 0.1% to 2.1%) and 9 of 271 (3.3%, 95% CI 1.5% to 6.2%) in RSV and non-RSV bronchiolitis, respectively (two sided Fisher's exact, *p*=.02).

Using logistic regression modified for rare events, younger age (OR 0.67 per month; 95% CI 0.45, 0.99) and a negative RSV antigen test (OR 6.22; 95% CI 1.30, 29.85) were associated with the composite endpoint. These results are presented graphically in the [Figure](#f1-wjem-11-60){ref-type="fig"}. Using ordinary logistic regression, age (OR 0.63 per month; 95% CI 0.43, 0.94) and a negative RSV antigen test (OR 7.77; 95%CI 1.61, 37.56) were associated with the primary or composite endpoint. The results were similar (age OR 0.57, RSV negative OR 4.81) when we analyzed the treating physicians' clinical impressions rather than study definitions of which infants had a positive EDSS or SBI.

The results were similar for the individual components (EDSS and SBI) of the endpoint. The prevalence of a positive EDSS was 7/605(1.1% 95% CI 0.4%, 2.2%); 1 of 334 (0.3%, 95% CI 0.0%, 1.7%) in the RSV group and 6 of 271 (2.2%, 95% CI 0.8%, 4.8%) in non-RSV bronchiolitis (two sided Fisher's exact, *p*=.049). Prevalence of a culture-proven SBI was 6/640 (0.9% 95% CI 0.3% to 2.0%). One of 334 (0.3%; 95% CI 0.0% to 1.7%) had RSV-positive and 5 of 271 (1.8%, 95% CI 0.06% to 4.3%) had RSV-negative bronchiolitis, (two-sided Fishers exact *p*=0.095).

Of the individual EDSS components, blood cultures were the most frequently obtained. However, urinary studies were the most likely to yield positive findings. Urine microscopy was performed in 95/640 (14.8%), urine cultures in 71/640 (11.0%), blood cultures in 183/640 (28.6%) and lumbar punctures in 10/640 (1.5%). Six out of 95 (6.3%) patients had \>10 WBC in on urine microscopy, 2/10 (20%) had \>10 WBC (corrected) in the CSF, and 7/71 (9.9%) had a positive urine culture. Twenty-one of 183 blood cultures grew organisms; of these, only two were recognized pathogens.

Prior antibiotic use did not seem to alter outcome; low colony count plates were not used in some children who had had prior antibiotics. The prevalence of SBI and EDSS in each age group is shown in [Table 3](#t3-wjem-11-60){ref-type="table"}.

DISCUSSION
==========

In children up to their eighteenth month of life with bronchiolitis, an EDSS was more likely to be performed in those who were less than two months old, febrile, dehydrated, and had more severe chest wall retractions; in short, those who appeared sicker. This evaluation was more likely to be positive in those who were younger and had a negative RSV antigen test. Once the decision to screen was made, neither fever nor the height of the fever was associated with SBI or positive EDSS. The paucity of positive outcomes despite relatively large sample size resulted in broad confidence intervals for our estimates of these effects.

Studies of febrile children have shown that when a viral etiology can be demonstrated, typically by RSV or influenza antigen testing, concurrent bacterial infection is rare.[@b1-wjem-11-60]--[@b3-wjem-11-60],[@b11-wjem-11-60],[@b19-wjem-11-60] Despite this, RSV status did not significantly affect the decision to obtain these tests in our study (RR 0.82 95% CI 0.65--1.04). Perhaps with larger numbers this trend would have reached significance. Similarly, in the presence of a recognizable viral illness concurrent bacterial infection is also unlikely.[@b11-wjem-11-60] We anticipated, and found, very low rates of culture- proven bacterial illness (0.9%) or EDSS (1.1%) in infants with bronchiolitis. One might reasonably expect, therefore, that RSV antigen testing would add little information in the risk stratification of these children. But it did, with a negative RSV test increasing the odds of EDSS or SBI by 6.22.

Why the prevalence of either a positive EDSS or SBI should differ in RSV as distinct from non-RSV bronchiolitis is a matter of conjecture. Although clinically indistinguishable, the inflammatory profile of RSV bronchiolitis differs from that of other viruses.[@b20-wjem-11-60]--[@b23-wjem-11-60]

A weakness in this study is that EDSS was variable in its components. Some children had blood, CSF and urine cultured, and some, typically older infants, only had urine cultured. This is inherent in the retrospective use of even prospectively collected research data. Even if a purely prospective design were employed, it would not be ethical to subject children to investigations that the treating clinician did not believe were indicated.

A related limitation is the possibility of a missed SBI in those not screened and who did not have an adverse outcome within three days of enrollment in the parent study. The most likely source in these cases would be urinary, and the most likely pathogen *Escherichia coli*, (*E. coli*). Where the infection is confined to the urinary tract it is possible that some infants would have cleared the infection spontaneously. Sepsis in conjunction with UTI occurred in 31% of neonates, 21% of infants aged 1 to 2 months, 14% of those aged two to three months, and 5.5% of infants over three months of age in one series.[@b24-wjem-11-60] Mortality rates as high as 45% to 73%, depending on the underlying prognosis, have been reported in children growing *E. coli* in blood cultures.[@b25-wjem-11-60] As there was only one death within 30 days of enrollment (in a severely co-morbid ex-premature infant), a clinically important miss rate for SBI in unscreened patients seems unlikely.

Another limitation is the use of RSV antigen rather than PCR testing. The sensitivity and specificity of the test we used is modest, 78 % and 67% respectively.[@b26-wjem-11-60] Whether and how PCR testing would have changed our results is speculative.

We chose our combined endpoint as the primary outcome for several reasons. Culture- negative SBI can occur, with diagnosis hinging on screening tests and clinical judgment. Our necessarily practical definition of EDSS in this study included only tests with a turnaround time short enough to impact ED management. Dropping "screen positive culture negative" cases does not help an EP who cannot know beforehand what cultures will grow.

Including screening tests alone would be incomplete. Although infants with urinary WBC\<10 are less likely to have a urinary tract infection,[@b27-wjem-11-60],[@b28-wjem-11-60] culturing is nonetheless recommended for all urine specimens obtained in this age group.[@b29-wjem-11-60] While CSF pleocytosis is suggestive, its absence in a neonate does not preclude meningitis.[@b30-wjem-11-60] Consequently, we felt that neither culture nor screening tests alone were a satisfactory outcome for emergency medicine.

Finally, when studying rare events, using a sensible combined outcome measure may allow insights to be obtained with smaller sample sizes than would otherwise be possible. The rarity of our outcome means that despite a sample size of 640 patients our confidence intervals are wide.

Our study definitions sometimes conflicted with the treating physicians' clinical impression of a coexisting bacterial illness. Two neonates who were treated based on CSF results were ultimately felt not to have an SBI. We categorized one of these cases as having a positive EDSS but negative SBI. One case was treated by the clinician as having a real UTI based on urine culture of gamma hemolytic *streptococcus*. We analyzed a case of *Candida glabrata* as having an EDSS and SBI in one patient who had pyuria. Though *C. glabrata* is often nosocomially acquired, it can be considered a non-trivial finding; this patient was treated.[@b31-wjem-11-60] Some have questioned whether urinary bacterial colony counts less than 50,000 in the presence of low urine WBC are significant. We had only one case where this may have been an issue; however, this infant has had two subsequent UTIs. While reluctant to discount the judgment of the treating pediatrician, we felt obliged to analyze the data according to our study definitions. Reassuringly, when we analyzed the data based on the physicians' clinical impressions the results were similar.

We were surprised that community antibiotic usage did not appear to affect the results. This may in part be because of the low prevalence of their use (11%). We were also surprised that blood cultures were ordered more frequently than urine cultures. They appear to have been ordered reflexively as part of the admission process in some cases.

Our overall prevalence of SBI was lower than some previous studies, which report a prevalence of SBI in bronchiolitis of 11.4%.[@b1-wjem-11-60] In RSV bronchiolitis specifically, the prevalence rates range from none to 7.0 %.[@b1-wjem-11-60],[@b32-wjem-11-60] Children with RSV negative bronchiolitis have also been found by most though not all others to have a higher prevalence of SBI.[@b1-wjem-11-60],[@b34-wjem-11-60]--[@b36-wjem-11-60] These studies excluded afebrile infants. We found that while the presence of fever influenced the decision to work up an infant, once that decision was made, neither the presence nor height of the fever was associated with a concurrent bacterial illness. Had we excluded infants who were afebrile on presentation we would not have been able to demonstrate this point. This approach also allowed us to capture the practice of experienced clinicians who occasionally perform an EDSS in infants without a fever yet look unwell.

Unlike prior work[@b2-wjem-11-60],[@b31-wjem-11-60],[@b34-wjem-11-60]--[@b36-wjem-11-60]we included children older than three months of age; this allowed us to prove the importance of age as a predictor of concurrent bacterial infection.

There are some differences between our findings and those of others that bear examination. In Liebelt et al 211 infants aged 90 days or younger with clinical bronchiolitis, no case of SBI was found. Of note, 82% of that study's patients had RSV-positive bronchiolitis.[@b33-wjem-11-60] Given that SBI is more likely in RSV negative patients and the CIs for 0/38 overlap with our findings, this apparent difference is likely artifactual. Antonow et al studied 282 infants less than two months of age with clinical bronchiolitis and found a SBI prevalence of 1.8%. In that study two-thirds of patients were febrile and RSV rate was 83 % (34). In our study, 32% were febrile on ED presentation (42% febrile in Liebelt and 65% in Antonow) and 55% were RSV-positive.

Most children, even the very young, will have neither a positive EDSS nor an SBI. Among those who do, a UTI is the most common diagnosis.[@b1-wjem-11-60],[@b2-wjem-11-60],[@b19-wjem-11-60],[@b32-wjem-11-60],[@b36-wjem-11-60] For individual patients, clinical judgment, which may be more cost effective than using "clinical rules,"[@b37-wjem-11-60] remains necessary. This study provides a measure of the underlying prevalence to help inform that judgment. We have not attempted to provide specific thresholds at which EDSS may be withheld. Instead we have provided our results in a way that we believe informs individual physicians' risk tolerance for what is a rare but important outcome.

Future work establishing the prevalence of concurrent bacterial lung infection in children with bronchiolitis is needed.

CONCLUSION
==========

In those children with bronchiolitis in whom ED testing for bacterial illness was performed, younger age and a negative RSV antigen test was associated with a positive EDSS or SBI.
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![Predicted probability of a positive emergency department septic screening or serious bacterial infection (SBI) by age and respiratory syncytial virus (RSV) testing results.](wjem-11-60f1){#f1-wjem-11-60}

###### 

Demographic and clinical information by RSV status

                                                    RSV Positive (N=334)   RSV Negative (N=271)   RSV Equivocal/Not Done (N=35)
  ------------------------------------------------- ---------------------- ---------------------- -------------------------------
  **Mean age, months (Median, IQR)**                5.3 (4.4, 5.6)         6.5 (5.0, 6.7)         7.4 (7.0, 7.8)
  **Male (%)**                                      193 (57.8)             163 (60.2)             15(42.9)
  **Premature, (%)** (\<37 wks gestation)           62 (18.6)              52(19.2)               5 (14.3)
  **Admission rate, (%)**                           167 (50.0)             80(30.0)               7 (20.0)
  **Median respiratory rate**                       45                     43                     42
  **Days ill before ED visit Mean (Median, IQR)**   4.8 (3, 3)             4.1 (3, 3)             6.0 (3, 6)
  **Temp, (°C)**                                    37.8                   37.7                   37.9
  **Mean Pulse oximetry, (%)**                      97                     97                     98
  **Febrile, (%)**                                                                                
  38.0°C-39.0°C (%)                                 78/334 (23.4)          46/271 (17.0)          7/35 (20.0)
  39.0°C-40.0°C (%)                                 24/324 (7.4)           24/271 (8.9)           3/35 (8.6)
  \>40°C, (%)                                       13/334 (3.9)           9/271 (3.3)            2/35 (5.7)
  **Normal Hydration, %**                           287/327 (87.8)         232/265 (87.6)         32/33 (97.0)
  5% Dehydrated, (%)                                27/327 (8.3)           27/265 (10.2)          1/33 (3.0)
  10% Dehydrated, (%)                               12/327 (3.7)           6/265 (2.3)            0/33 (0.0)
  15% Dehydrated, (%)                               1/327 (0.3)            0/265 (0.0)            0/33 (0.0)
  **Retraction Severity**                                                                         
  None                                              24 (7.8)               17 (6.8)               4 (13.3)
  Mild                                              148 (48.2)             129 (51.2)             14 (46.7)
  Moderate                                          120 (39.1)             94 (37.3)              12 (40.0)
  Severe                                            15 (4.9)               12 (4.8)               0 (0.0)
  Community antibiotic use                          34/328 (10.5)          31/266 (11.8)          6/35 (17.1)
  **Steroid use (%)**                               15/334 (4.5)           10/271 (3.7)           2/35 (5.7)

*RSV*, Respiratory Syncytial Virus; *IQR*, *interquartile range; ED*, emergency department.

###### 

Details of infants with a positive outcome.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **ID**   **AGE**            **RSV**   **Sex**   **Blood Culture**           **Urine WBC units**   **Urine Culture**                                  **CSF WBC units**   **Classification for Analysis**   **Comments**
  -------- ------------------ --------- --------- --------------------------- --------------------- -------------------------------------------------- ------------------- --------------------------------- --------------------------------------------------------------------------------------
  7        43 days            \+        M         Coag neg *staphylococcus*   9                     *Klebsiella* coag neg *staphyloccus E. faecalis*   0                   EDSS −\                           Clinician considered blood culture significant and treated but analyzed as negative.
                                                                                                                                                                           SBI −                             

  2        19 days            \-        M         Coag neg *staphylococcus*   1                     No growth                                          12                  EDSS −\                           Treated initially as meningitis. CSF Protein 93 but analyzed as negative
                                                                                                                                                                           SBI −                             

  3        23 days            \+        F         none                        0                     Gamma hemolytic *streptococcus*                    0                   EDSS −\                           Febrile. Considered a real SBI by the treating clinician but analyzed as negative.
                                                                                                                                                                           SBI −                             

  4        27 days            \-        F         none                        51                    No growth                                          0                   EDSS +\                           
                                                                                                                                                                           SBI −                             

  5        35 days            \-        F         none                        405                   *E.coli*                                           0                   EDSS +\                           
                                                                                                                                                                           SBI +                             

  6        43 days            \+        M         Group B *streptococcus*     Not done              No growth                                          0                   EDSS--\                           
                                                                                                                                                                           SBI +                             

  1        13 days            \-        M         None                        0                     Contaminant                                        40                  EDSS +\                           CSF culture negative. Analyzed as EDSS only +
                                                                                                                                                                           SBI −                             

  8        48 days            \-        M         none                        2                     *Klebsiella pneumoniae*                            0                   EDSS −\                           SBI positive urine culture. Subsequently had two more UTIs.
                                                                                                                                                                           SBI+                              

  9        51 days            \-        M         none                        46                    *Candida glabrata*                                 0                   EDSS+\                            *C. glabrata* considered significant by clinician.
                                                                                                                                                                           SBI+                              

  10       59 days            \-        F         none                        12                    Not done                                           0                   EDSS+\                            
                                                                                                                                                                           SBI−                              

  11       56 days            \-        M         none                        5                     *E.coli*                                           0                   EDSS −\                           SBI Positive urine culture.
                                                                                                                                                                           SBI+                              

  12       87 days            \+        F         Coag neg *staphylococcus*   21                    Coag neg *staphyloccus*                            0                   EDSS+ SBI−                        Clinician considered cultures significant and treated but analyzed as EDSS + SBI−

  13       4 months 12 days   \-        M         Not Done                    12                    Not done                                           0                   EDSS+\                            
                                                                                                                                                                           SBI−                              

  14       7 months 3 days    \-        F         *Staphylococcus aureu*s     Not done              Not done                                           0                   EDSS −\                           
                                                                                                                                                                           SBI +                             
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*RSV*, Respiratory Syncytial Virus; *WBC*, white blood count; *CSF*, cerebrospinal fluid; *EDSS*, emergency department septic screening; *SBI*, serious bacterial infection.

###### 

Prevalence of Respiratory Syncytial Virus (RSV) and serious bacterial infection (SBI) or emergency department septic screening (EDSS) by age.

  **Age (months)**   **RSV positive (%)[\*](#tfn3-wjem-11-60){ref-type="table-fn"}**   **SBI (%)**   **EDSS (%)**   **Combined (%)**
  ------------------ ----------------------------------------------------------------- ------------- -------------- ------------------
  \<1                31/41 (76)                                                        0/43 (0)      2/43 (4.7)     2/43 (4.7)
  1-2                57/95 (60)                                                        5/96 (5.2)    3/96 (3.1)     6/96 (6.3)
  2-3                46/76 (61)                                                        0/80 (0)      1/80 (1.3)     1/80 (1.3)
  3-4                18/50 (36)                                                        0/52 (0)      0/52 (0)       0/52 (0)
  4-5                32/55 (58)                                                        0/60 (0)      1/60 (1.7)     1/60 (1.7)
  5-6                33/54 (61)                                                        0/57 (0)      0/57 (0)       0/57 (0)
  6+                 117/234 (50)                                                      1/252 (0)     0/252 (0)      1/252 (0.4)
  Total              334/605 (52)                                                      6/640 (0.9)   7/640 (1.1)    11/640 (1.7)

Excludes cases where RSV testing was equivocal or not performed.
